sample_id,dataset,series,subtype,date_of_birth,date_diagnosis,date_surgery,breast_surgery,axillary_surgey,histotype,vascular_emboly,multifocal,multifocal_nr,bilateral,nature_controlateral_cancer,tumor_size_mm_1,tumor_size_mm_2,tumor_size_mm_3,tumor_size_mm_4,nodes_pos,nodes_extracted,SBR,grade,er_score,total,er_status,pgr_score,total,pgr_status,her2_IHC,her2_FISH,HER2/CR 17,HER2_status,Ki67,menopause,chemo_adjuvant,hormono_adjuvant,RT_adjuvant,adjuvant_herceptin (H),treatment_adjuvant,date_invasive_ipsilateral_breast_rec,date_local/regional_invasive_rec,date_invasive_controlateral_rec,date_distant_rec,site_distant_rec,date_ipsilateral_DCIS,date_controlateral_DCIS,date_second_primary_invasive_tumor,site_second_primary_invasive_tumor,last_FU,date_death,cause_death,commentsTN 1,PNC Seq,FIRST,TN,20-Aug-66,18-Oct-07,09-Nov-07,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,13,NA,NA,NA,0,3,9,3,0,8,0,0,8,0,0,NA,NA,0,90,0,1,0,1,NA,3 FEC _ 3 T,NA,NA,NA,NA,NA,NA,NA,NA,NA,08-Dec-11,NA,NA,Tretaed 6 years for fertility problemsTN 2,PNC Seq,FIRST,TN,27-Apr-60,04-Oct-07,29-Feb-08,mastectomy,NA,ductal,1,0,NA,0,NA,50,NA,NA,NA,NA,NA,9,3,0,8,0,0,8,0,0,NA,NA,0,90,1,0,0,0,NA,SEE COMMENTS,NA,NA,NA,01-Mar-07,lung,NA,NA,NA,NA,15-Jun-09,NA,NA,"T4b, locally advanced, metastatic ab initio, treated with 2X 5FU+carboplatin+Pharmarubicine intra-arterial in Ukraine _4XFEC_SURGERY_2XEC_16X weekly Taxol_ 9X xeloda"TN 3,PNC Seq,FIRST,TN,19-Mar-49,17-Apr-08,13-May-08,tumorectomy,dissection,ductal,0,0,NA,0,NA,20,NA,NA,NA,0,11,9,3,0,8,0,0,8,0,0,NA,NA,0,30,1,1,0,0,NA,1 cycle EC,NA,NA,NA,NA,NA,NA,NA,NA,NA,21-Aug-08,NA,NA,In treatment with immunosoppressors for renal graft in 01/2001 and hormotherapy for menopausal for several years; psicTN 4,PNC Seq,FIRST,TN,28-Feb-42,10-Sep-07,17-Dec-07,tumorectomy,dissection,ductal,0,0,NA,0,NA,18,NA,NA,NA,2,16,9,3,0,8,0,0,8,0,0,NA,NA,0,90,1,1,0,1,NA,4 TC,NA,NA,NA,NA,NA,NA,NA,NA,NA,11-Feb-11,NA,NA,"CT neoadjuvant, TOP trial"TN 5,PNC Seq,FIRST,TN,18-Apr-69,11-Mar-08,07-Apr-08,mastectomy,dissection,ductal,0,0,NA,0,NA,42,NA,NA,NA,0,16,9,3,0,8,0,0,8,0,0,NA,NA,0,90,0,1,0,1,NA,4 EC dose-dense_TC,NA,NA,NA,NA,NA,NA,NA,NA,NA,22-Sep-11,NA,NA,TN 15,PNC Seq,THIRD,TN,08-Jun-74,26-Nov-09,18-Dec-09,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,17,NA,NA,NA,0,2,9,3,0,8,0,0,8,0,0,NA,NA,0,90,0,1,0,1,NA,3 FEC _ 3 T,NA,NA,NA,NA,NA,NA,NA,NA,NA,27-Jan-12,NA,NA,"Enrolled in MINDACT(high genomic risk), PACS08; BRCA1 MUTATED; 1 year before surgery, bilateral breast plastic surgery; oral contraceptive stopped before surgery"TN 16 ,PNC Seq,THIRD,TN,03-Jul-55,31-Dec-07,12-Feb-08,tumorectomy,dissection,ductal,1,0,NA,0,NA,17,NA,NA,NA,6,26,9,3,0,8,0,0,8,0,0,NA,NA,0,60,1,1,0,1,NA,3 FEC _ 3 T,NA,NA,NA,25-May-09,"lung and pleura, lymph nodes, liver, mediastinic, peritoneal carcinomatosis",NA,NA,NA,NA,NA,16-Oct-09,cancer,"1993 surgery for invasive ductal carcinoma, TN, trated with RT, 6X CMF, tamoxifen for 2 years; MINDACT; Maybe some metastatic tissue available"TN 17,PNC Seq,THIRD,TN,20-Nov-73,10-Jan-08,05-Feb-08,mastectomy,dissection,ductal,0,1,2,0,NA,11,9,NA,NA,0,22,8,3,0,8,0,0,8,0,0,NA,NA,0,70,0,1,0,1,NA,4 EC _12 weekly T,NA,NA,NA,NA,NA,NA,NA,NA,NA,29-Nov-11,NA,NA,"1st focus: 11 mm,metaplastic (mixte, with chondroid metaplasia), SBR9, G3; 2nd: 9 mm, ductal, SBR8, G3"TN 18,PNC Seq,THIRD,TN,04-May-49,10-Nov-10,03-Dec-10,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,14,NA,NA,NA,0,2,7,2,0,8,0,0,8,0,0,NA,NA,0,30,1,0,0,1,NA,NA,NA,NA,NA,20-Jan-11,lung,NA,NA,NA,NA,16-Nov-11,NA,NA,Maybe some metastatic tissue availableTN 19,PNC Seq,THIRD,TN,19-Sep-59,22-Jan-10,22-Jan-10,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,20,NA,NA,NA,0,3,9,3,0,8,0,0,8,0,0,NA,NA,0,80,0,1,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,05-Dec-11,NA,NA,St PierreTN 20,PNC Seq,THIRD,TN,23-Nov-58,05-Nov-09,27-Nov-09,mastectomy,dissection,ductal,0,0,NA,0,NA,19,NA,NA,NA,0,13,9,3,0,8,0,0,8,0,0,NA,NA,0,80,1,1,0,0,NA,6 TC,NA,NA,NA,NA,NA,NA,NA,NA,NA,26-Nov-11,NA,NA,"2001:tumorectomy+axillary dissection for controlateral ductal carcinma, 14mm, 2 lymph nodes invaded/22, ER+, PgR+, SBR6, G2, HER2-, tretaed with 6XFEC_tamoxifen_femara up to 05/2009; Maybe some metastatic tissue available"TN 21,PNC Seq,THIRD,TN,11-Feb-55,12-Nov-10,14-Dec-10,mastectomy,dissection,ductal,0,1,2,0,NA,16,3,NA,NA,0,15,9,3,0,8,0,0,8,0,0,NA,NA,0,80,1,1,1,0,NA,3 FEC _ 3 T,NA,NA,NA,NA,NA,NA,NA,NA,NA,10-Aug-11,NA,NA,"MINDACT; thesecond lesion was 3 mm and removed with a tru-cut; it was ductal carcinoma, G1, ER+, PgR-, HER2 1+, ki6710"TN 22,PNC Seq,THIRD,TN,09-Jan-72,12-Aug-10,14-Feb-11,tumorectomy,dissection,ductal,1,1,2,0,NA,12,12,NA,NA,0,16,9,3,0,8,0,0,8,0,0,NA,NA,0,50,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,07-Dec-11,NA,NA,Patient treated with CT neoadjuvante 6 X FEC; A pre-treatment biopsy done in another hospital show positivity for ER; RCB II; BRCA ongoingTN 23,PNC Seq,THIRD,TN,01-Jul-45,29-Apr-20,16-Jun-10,tumorectomy,sentinelle,ductal/lobular,0,0,NA,0,NA,15,NA,NA,NA,0,2,6,2,0,8,0,0,8,0,1,NA,NA,0,10,1,1,0,1,NA,3 FEC _ 3 T,NA,NA,NA,NA,NA,NA,NA,NA,NA,08-Feb-12,NA,NA,not clear if ductal or lobular; the patient has probably a cancer of the ovary but not clear; ongoingTN 24,PNC Seq,THIRD,TN,06-Dec-47,15-Feb-11,15-Mar-11,tumorectomy,dissection,ductal,0,0,NA,0,NA,16,NA,NA,NA,0,22,8,3,0,8,0,0,8,0,0,NA,NA,0,30,1,1,0,1,NA,4 FEC _ 3 T,NA,NA,NA,NA,NA,NA,NA,NA,NA,11-Oct-11,NA,NA,"possible apocrine differentiation; in external biopsy, IHC for HEr2 2+, FISH-"TN 25,PNC Seq,THIRD,TN,25-Mar-32,14-Oct-10,14-Oct-10,mastectomy,dissection,ductal,1,1,2,0,NA,21,15,NA,NA,0,23,8,3,0,8,0,0,8,0,0,NA,NA,0,20,1,0,0,0,0,See COMMENTS,NA,NA,NA,NA,NA,NA,NA,NA,NA,20-Oct-10,NA,NA,"Hopital d'Ixelles; 2nd lesion 15 mm; pts was blind and deaf, family refused any further treatment"TN 26,PNC Seq,THIRD,TN,09-Jan-27,17-Dec-07,24-Jan-08,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,12,NA,NA,NA,0,1,8,3,0,8,0,0,8,0,1,NA,NA,0,30,1,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,23-11-2011,NA,NA,TN 27,PNC Seq,THIRD,TN,23-Jun-53,25-Mar-10,06-Apr-10,tumorectomy,sentinelle,ductal,1,0,NA,0,NA,18,NA,NA,NA,0,2,9,3,0,8,0,0,8,0,3,1,2.3,1,80,1,1,0,1,1,4 EC dose dense_12T+H weekly_H,NA,NA,NA,NA,NA,NA,NA,NA,NA,01-Feb-12,NA,NA,"It was considered HER2 neg; after re-evaluation, it turned out to be HER2 pos (FISH value is on the biopsy); 05 July 2006: mastectomy of the same side for ductal carcinoma in situ; G3, ER/PgR neg; HER2+, lymph 0/13"TN 28,PNC Seq,THIRD,TN,28-Jan-57,21-Sep-10,25-Oct-10,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,11,NA,NA,NA,0,1,9,3,0,8,0,0,8,0,0,NA,NA,0,80,1,1,0,1,NA,5 FEC _ 1 T,NA,NA,NA,NA,NA,NA,NA,NA,NA,05-Dec-11,NA,NA,Traitement hormonal substitutif; MINDACT high riskHER2 1,PNC Seq,FIRST,HER2,13-Jan-58,12-Mar-08,01_April-2008,tumorectomy,dissection,ductal,0,0,NA,0,NA,18,NA,NA,NA,0,14,8,3,7,8,1,4,8,1,3,1,8.73,1,15,1,1,1,1,1,3 FEC _ 3 T_H+anastrozole_anastrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,31-Jan-12,NA,NA,Treatment with herceptin not completed for cardiac tossicityHER2 2,PNC Seq,FIRST,HER2,30-Aug-25,09-Jun-08,08-Jul-08,tumorectomy,dissection,ductal,0,0,NA,0,NA,34,NA,NA,NA,1,18,9,3,6,8,1,3,8,1,3,1,8.67,1,40,1,0,1,1,1,H+anastrozole_anastrozole_letrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,22-Feb-12,NA,NA,FISH on biopsy; both herceptin and Arimidex stopped for cardiac tossicityHER2 3,PNC Seq,FIRST,HER2,02-Aug-73,14-Jul-08,14-Jul-08,mastectomy,dissection,ductal,1,0,NA,0,NA,70,NA,NA,NA,6,17,8,3,5,8,1,7,8,1,3,1,5.25,1,20,0,1,1,1,1,"3 FEC_3 T_H_lapatinib; in parallel,zoladex+tam_tam",NA,NA,NA,NA,NA,NA,NA,NA,NA,31-Jan-12,NA,NA,ALTTO trialHER2 4,PNC Seq,FIRST,HER2,21-Mar-64,17-Jul-08,05-Sep-08,tumorectomy,dissection,ductal,1,0,NA,0,NA,27,NA,NA,NA,1,7,8,3,0,8,0,0,8,0,3,1,2.72,1,15,0,1,0,1,1,3 FEC_3 T_H,NA,NA,NA,NA,NA,NA,NA,NA,NA,20-Sep-11,NA,NA,MINDACT high genomic riskHER2 5,PNC Seq,FIRST,HER2,15-Jul-28,02-Dec-83,05-Mar-09,mastectomy,sentinelle,ductal,0,0,NA,0,NA,20,NA,NA,NA,0,1,7,2,0,8,0,0,8,0,3,1,6.08,1,15,1,1,1,1,1,SEE COMMENTS,NA,NA,05-Mar-09,05-Feb,"bones, liver, lung, brain",NA,NA,NA,NA,NA,24-Mar-11,cancer,"1983:mastectomy for ductal carcinoma,ER+, not treated; 2005:metastasis bones treated with HT; 2006: M+ pterygo-maxillare, 2008: M+ maxillare;2009: controlateral cancer treated with Aromasin;2010: M+ liver, lung, bones treated with cisplatine-Herceptin; End 2010: M+ brain"HER2 13,PNC Seq,THIRD,HER2,14-May-63,18-Feb-09,07-Apr-09,tumorectomy,dissection,ductal,0,0,NA,0,NA,17,NA,NA,NA,3,23,8,3,8,8,1,8,8,1,3,1,5.32,1,35,0,1,1,1,1,4 FEC _ H+tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,07-Apr-11,NA,NA,"FISH on biopsy; MINDACT: high clinical risk; low genomic risk, "HER2 14 ,PNC Seq,THIRD,HER2,30-May-61,27-Jul-10,13-Aug-10,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,16,NA,NA,NA,0,7,8,3,6,8,1,5,8,1,3,1,12.74,1,25,0,1,1,1,1,3 FEC_3 T+H_H+ tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,09-Nov-11,NA,NA,"FISH done on the biopsy; MINDACT, both high clinical and genomic risk; 15 Dec 1986: omolateral surgery for fibro-adenoma"HER2 15 ,PNC Seq,THIRD,HER2,21-Sep-63,08-Dec-08,06-Jan-09,mastectomy,dissection,ductal,1,1,2,0,NA,13,12,NA,NA,0,14,9,3,8,8,1,8,8,1,3,1,2.73,1,20,0,1,1,1,1,4 FEC_3 T+H_H+ tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,17-Feb-12,NA,NA,HER2 16 ,PNC Seq,THIRD,HER2,04-Mar-51,08-Jul-09,20-Jul-09,tumorectomy,dissection,colloid(mucinoux),0,0,NA,0,NA,24,NA,NA,NA,2,10,7,2,6,8,1,0,8,0,3,1,9.15,1,25,1,1,1,1,1,5 FEC_3 T+H_H+ tamoxifen_letrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,17-Feb-12,NA,NA,MINDACT (both clinical and genomic high risk); considered ductalHER2 18,PNC Seq,THIRD,HER2,10-Nov-53,06-Nov-91,20-Jan-08,mastectomy,dissection,ductal,1,0,NA,0,NA,140,NA,NA,NA,5,15,8,3,4,8,1,2,8,0,3,1,12,1,15,0,1,1,1,1,SEE COMMENTS,NA,NA,29-Sep-07,16-Jun-05,"lymph nodes, bones,skin",NA,NA,NA,NA,02-Feb-12,NA,NA,"micropapillary differentiation; 06 Nov 1991: mastectomy for controlateral ductal carcinoma, G2, 2+/12 lymph nodes treated with 6 CMF+RT; 2005: Met lymph nodes and bones, treated with 2X herceptin -Velcade_progression_6X herceptin-taxol_Herceptin-Zometa; 2007: Met cerebellum+ controlateral cancer_3X caelyx_surgery_lapatinib-xeloda_tamoxifen_cisplatin 5FU+herceptin+Zometa_herceptin_femara_progresssio_herceptin+Navelbine_progression_lapatinib-xeloda_progression; maybe primary tumor"HER2 19 ,PNC Seq,THIRD,HER2,26-Aug-48,20-Oct-08,18-Nov-08,tumorectomy,dissection,ductal,0,0,NA,0,NA,17,NA,NA,NA,2,12,7,2,8,8,1,0,8,0,3,1,5.77,1,35,1,1,1,1,1,4 TCH_H+anastrozole,NA,NA,NA,30-Sep-10,"lymph nodes, liver",NA,NA,NA,NA,10-Feb-12,NA,NA,HER2 20 ,PNC Seq,THIRD,HER2,07-Nov-41,22-Apr-08,19-Jun-08,tumorectomy,dissection,ductal,0,0,NA,0,NA,22,NA,NA,NA,2,12,9,3,7,8,1,8,8,1,3,1,3.32,1,40,1,1,1,1,1,3 FEC_3 T_H+ anastrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,26-Dec-11,NA,NA,HER2 21 ,PNC Seq,THIRD,HER2,18-Jun-64,03-Dec-10,18-Jan-11,mastectomy,sentinelle,ductal,0,0,NA,0,NA,13,NA,NA,NA,0,2,9,3,0,8,0,0,8,0,3,1,5.42,1,70,0,1,0,1,0,1 TC_herceptin,NA,NA,NA,NA,NA,NA,NA,NA,NA,15-Feb-12,NA,NA,"06/2009: bilateral tumorectomy for DCIS grade I (left) and grade III (right, same side as surgery) followed by radiotherapy"HER2 22 ,PNC Seq,THIRD,HER2,23-Dec-70,05-Feb-10,09-Mar-10,mastectomy,dissection,ductal,0,1,2,0,NA,13,12,NA,NA,1,15,7,2,7,8,1,4,8,0,3,1,10.83,1,30,0,1,1,1,1,3 FEC_3 T_H+ tamoxifen+zoladex,NA,NA,NA,NA,NA,NA,NA,NA,NA,10-Feb-12,NA,NA,MINDACT (high clinical and genomic risk); Immunohistochemistry done on biggest lesionHER2 23 ,PNC Seq,THIRD,HER2,05-Dec-52,24-Sep-07,23-Oct-07,tumorectomy,dissection,ductal,0,0,NA,0,NA,25,NA,NA,NA,1,11,7,2,7,8,1,0,8,0,2,1,5.08,1,2,1,1,1,1,1,4 FEC _ herceptin+ letrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,07-Nov-11,NA,NA,"MINDACT (high clinical, low genomic risk); IMPORTANT: 2 populations have been found, one HER2 neg and 1 HER2 positive"HER2 24 ,PNC Seq,THIRD,HER2,05-Oct-59,16-Oct-08,18-Nov-08,tumorectomy,dissection,ductal,0,0,NA,0,NA,25,NA,NA,NA,1,10,9,3,3,8,1,0,8,0,3,1,6.8,1,50,1,1,1,1,1,3 FEC_3 T_H+ anastrozole,NA,NA,NA,21-Jun-10,liver,NA,NA,NA,NA,NA,15-Aug-11,cancer,MINDACTLUMA 1,PNC Seq,FIRST,LUMA,08-Aug-65,16-Oct-07,20-Nov-07,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,14,NA,NA,NA,0,2,5,1,8,8,1,8,8,1,0,NA,NA,0,10,0,0,1,1,0,tamoxifen-zoladex few months_tamoxifen 5 years.,NA,NA,NA,NA,NA,NA,NA,NA,NA,01-Dec-11,NA,NA,LUMA 2,PNC Seq,FIRST,LUMA,09-Jan-63,29-Nov-07,27-Dic-2007,tumorectomy,dissection,ductal,0,0,NA,0,NA,18,NA,NA,NA,0,13,5,1,7,8,1,8,8,1,0,NA,NA,0,10,0,0,1,1,0,tamoxifen-zoladex_tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,18-Jan-12,NA,NA,LUMA 3,PNC Seq,FIRST,LUMA,12-Sep-59,07-Aug-08,03-Feb-09,tumorectomy,dissection,ductal,0,0,NA,0,NA,24,NA,NA,NA,0,13,5,1,8,8,1,7,8,1,0,NA,NA,0,5,1,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,01-Apr-09,NA,NA,LUMA 4,PNC Seq,FIRST,LUMA,25-Apr-47,24-Jan-08,28-Feb-08,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,18,NA,NA,NA,0,1,5,1,8,8,1,7,8,1,0,NA,NA,0,10,1,0,1,1,0,5 years tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,03-Feb-12,NA,NA,LUMA 5,PNC Seq,FIRST,LUMA,08-Nov-63,09-Feb-10,16-Mar-10,tumorectomy,dissection,ductal,0,1,4,0,NA,12,9,5,5,0,9,4,1,7,8,1,8,8,1,0,NA,NA,0,10,0,0,1,1,0,tamoxifen-zoladex_tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,29-Sep-11,NA,NA,LUMA 18,PNC Seq,THIRD,LUMA,18-Jun-46,08-Apr-09,19-May-09,tumorectomy,dissection,ductal,0,0,NA,0,NA,24,NA,NA,NA,0,12,4,1,8,8,1,6,8,1,0,NA,NA,0,5,1,0,1,1,0,5 years AI,NA,NA,NA,NA,NA,NA,NA,NA,NA,24-Oct-11,NA,NA,Switch of AILUMA 19 ,PNC Seq,THIRD,LUMA,07-Jul-72,09-Nov-09,22-Dec-09,tumorectomy,dissection,ductal,0,0,NA,0,NA,20,NA,NA,NA,0,13,4,1,8,8,1,8,8,1,0,NA,NA,0,10,0,0,1,1,0,2 years tamoxifen_?,NA,NA,NA,NA,NA,NA,NA,NA,NA,06-Jan-01,NA,NA,LUMA 20,PNC Seq,THIRD,LUMA,26-May-61,11-Nov-11,13-Nov-11,mastectomy,dissection,lobular,0,1,3,0,NA,9,9,4,NA,0,18,5,1,8,8,1,8,8,1,0,NA,NA,0,10,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,23-Feb-12,NA,NA,LUMA 21 ,PNC Seq,THIRD,LUMA,13-Jun-56,08-Nov-07,13-Dec-07,mastectomy,dissection,ductal,0,0,NA,0,NA,17,NA,NA,NA,0,15,5,1,8,8,1,8,8,1,0,NA,NA,0,5,0,0,1,NA,0,tamoxifen-zoladex_tamoxifen,NA,NA,NA,01-Mar-10,"bones,lymp nodes",NA,NA,12-Feb-10,endometrium,18-Nov-11,NA,NA,"The metastasis are considered as coming from the endometrium, not the breast"LUMA 22,PNC Seq,THIRD,LUMA,03-Jun-46,04-Dec-07,15-Jan-08,tumorectomy,sentinelle,ductal,0,0,NA,1,"Tubular carcinoma, 3mm, G1",13,NA,NA,NA,0,3,5,1,7,8,1,7,8,1,0,NA,NA,0,5,1,0,1,1,0,5 years tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,15-Mar-11,NA,NA,LUMA 23 ,PNC Seq,THIRD,LUMA,26-Jan-36,11-Dec-08,08-Jan-09,mastectomy,dissection,ductal,0,0,NA,0,NA,20,NA,NA,NA,1,14,5,1,8,8,1,0,8,1,0,NA,NA,0,10,1,0,1,0,0,5 years tamoxifen,NA,NA,NA,NA,NA,NA,NA,17-Oct-11,brain,16-Feb-12,NA,NA,The brain lesion is considered as a promary tumor. No histology is availableLUMA 24 ,PNC Seq,THIRD,LUMA,19-Mar-48,05-Jan-11,25-Jan-11,tumorectomy,dissection,ductal,0,0,NA,0,NA,12,NA,NA,NA,1,17,5,1,8,8,1,8,8,1,0,NA,NA,0,10,1,0,1,1,0,5 years anastrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,29-Dec-11,NA,NA,LUMA 25 ,PNC Seq,THIRD,LUMA,21-Jul-52,05-Feb-10,05-Feb-10,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,9,NA,NA,NA,0,1,5,1,8,8,1,8,8,1,0,NA,NA,0,5,1,0,1,1,0,5 years tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,25-Feb-11,NA,NA,St Pierre;LUMA 26 ,PNC Seq,THIRD,LUMA,03-Aug-44,06-Apr-10,04-May-10,tumorectomy,dissection,ductal,0,0,NA,0,NA,33,NA,NA,NA,0,25,5,1,8,8,1,8,8,1,0,NA,NA,0,20,1,1,1,1,0,4 EC _letrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,01-Dec-11,NA,NA,Traitement hormonal substitutif for about 17 years; MINDACT (high clinical risk; low genomic risk)LUMA 27,PNC Seq,THIRD,LUMA,15-Aug-48,12-Jan-11,01-Mar-11,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,18,NA,NA,NA,0,3,5,1,8,8,1,8,8,1,0,NA,NA,0,5,1,0,1,1,0,5 years tamoxifen,NA,NA,NA,NA,NA,NA,NA,22-Apr-10,colon,24-Feb-12,NA,NA,The patient has liver metastasis of her colon cancerLUMA 28 ,PNC Seq,THIRD,LUMA,16-Apr-45,10-Aug-09,07-Sep-09,tumorectomy,dissection,ductal,0,0,NA,0,NA,20,NA,NA,NA,1,12,5,1,8,8,1,8,8,1,0,NA,NA,0,5,1,0,1,1,0,2 years tamoxifen_5 years letrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,25-0ct-2011,NA,NA,MINDACT (both low clinical and genomic risk)LUMA 29 ,PNC Seq,THIRD,LUMA,21-Jan-60,25-Mar-11,23-May-11,mastectomy,dissection,ductal,1,0,NA,0,NA,45,NA,NA,NA,1,12,5,1,8,8,1,8,8,1,0,NA,NA,0,10,0,1,1,1,0,3 FEC_3 taxotere_letrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,05-Feb-12,NA,NA,2008:diagnosis of homolateral sclerosant adenosis LUMA 31,PNC Seq,THIRD,LUMA,13-Nov-25,15-Nov-10,17-Dec-10,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,15,NA,NA,NA,0,4,5,1,8,8,1,8,8,1,0,NA,NA,0,10,1,0,1,1,0,5 years tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,09-Nov-11,NA,NA,LUMA 32 ,PNC Seq,THIRD,LUMA,25-Oct-52,26-Jul-10,05-Oct-10,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,11,NA,NA,NA,0,1,4,1,8,8,1,8,8,1,0,NA,NA,0,10,1,0,0,1,0,tamoxifen for 10 days,NA,NA,NA,NA,NA,NA,NA,NA,NA,21-Oct-11,NA,NA,1995: diagnosis of 2 homolateral intracanalar fibroadenomes LUMA 33,PNC Seq,THIRD,LUMA,14-May-41,23-01-2009,23-01-2009,tumorectomy,dissection,ductal,0,0,NA,0,NA,17,NA,NA,NA,0,NA,4,1,8,8,1,6,8,1,0,NA,NA,0,10,1,0,1,1,0,5 years tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,17-Jan-12,NA,NA,LUMB 1,PNC Seq,FIRST,LUMB,19-Aug-65,31-Oct-07,12-Nov-07,tumorectomy,dissection,ductal,0,0,NA,0,NA,10,NA,NA,NA,4,18,9,3,7,8,1,8,8,1,0,NA,NA,0,30,0,1,1,1,0,3 FEC_3 T_tamoxifen+zoladex_anastrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,17-Nov-11,NA,NA,LUMB 2,PNC Seq,FIRST,LUMB,09-Feb-33,19-May-08,03-Jun-08,mastectomy,dissection,ductal,0,1,2*,0,NA,40,15,NA,NA,0,20,8,3,8,8,1,0,8,0,0,0,1.77,0,15,1,0,1,1,0,AI,NA,NA,NA,27-Nov-08,liver?pancreas?,NA,NA,27-Nov-08,liver?pancreas?,30-Dec-08,NA,NA,*the first lesion was actually made up by 3 smaller lesions; FISH for HER done on biopsy was positive; patient underwent a long traitement hormonal substitutif; not clear if lesions were primary or metastasis of the breast cancerLUMB 3,PNC Seq,FIRST,LUMB,09-Jun-55,28-May-08,24-Jun-08,tumorectomy,sentinelle,micropapillary,0,0,NA,0,NA,10,NA,NA,NA,1,3,8,3,8,8,1,8,8,1,0,NA,NA,0,8,1,0,1,1,0,2 years tam_3 years exemestane,NA,NA,NA,NA,NA,NA,NA,NA,NA,07-Nov-11,NA,NA,"14-Jul-2006: hysterectomy for cystadenome mucinous border line"LUMB 4,PNC Seq,FIRST,LUMB,01-Jan-64,30-Sep-08,16-Oct-08,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,10,NA,NA,NA,0,1,8,3,8,8,1,5,8,1,0,NA,NA,0,20,0,1,1,1,0,6 FEC_tamoxifen-zoladex_exemestane,NA,NA,NA,NA,NA,NA,NA,NA,NA,10-Feb-12,NA,NA,LUMB 5,PNC Seq,FIRST,LUMB,28-Apr-67,31-Mar-09,08-May-09,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,20,NA,NA,NA,1,12,9,3,3,8,1,0,8,0,0,NA,NA,0,70,0,1,1,1,0,4 EC _ 12 weekly taxol _tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,19-Dec-11,NA,NA,LUMB 15,PNC Seq,THIRD,LUMB,20-Apr-31,28-Jun-10,14-Jul-10,mastectomy,dissection,ductal,1,0,NA,0,NA,25,NA,NA,NA,3,15,9,3,8,8,1,8,8,1,0,NA,NA,0,20,1,0,1,0,0,anastrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,10-Dec-12,NA,NA,LUMB 17 ,PNC Seq,THIRD,LUMB,04-Jun-51,30-Jan-08,08-Feb-08,tumorectomy,dissection,ductal,0,0,NA,0,NA,23,NA,NA,NA,0,5,8,3,8,8,1,0,8,0,0,NA,NA,0,10,1,1,1,1,0,6 FEC_anastrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,08-Sep-11,NA,NA,LUMB 18 ,PNC Seq,THIRD,LUMB,10-Aug-48,12-Jan-10,26-Jan-10,mastectomy,dissection,ductal,0,0,NA,0,NA,20,NA,NA,NA,0,13,8,3,7,8,1,5,8,1,0,NA,NA,0,20,1,1,1,0,0,6 FEC 100_tamoxifen,NA,NA,NA,NA,NA,NA,NA,,NA,26-Jan-12,NA,NA,"08-dec-2008: controlateral tumorectomy for ductal carcinoma, G2, with lymph node micrometatstasis, ER/PgR positive, ki6720%; we maybe have the controlateral tumor"LUMB 19 ,PNC Seq,THIRD,LUMB,19-Sep-97,01-Apr-11,11-Apr-11,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,18,NA,NA,NA,0,1,9,3,4,8,1,0,8,0,0,NA,NA,0,90,0,1,1,1,0,6 EC dd (reaction to T)_tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,23-Jan-12,NA,NA,BRCA 2 inactivant mutationLUMB 20,PNC Seq,THIRD,LUMB,18-May-66,20-May-11,20-May-11,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,11,NA,NA,NA,0,4,9,3,8,8,1,8,8,1,0,NA,NA,0,20,0,1,1,1,0,AC_tamoxifen,NA,NA,NA,NA,NA,NA,NA,NA,NA,16-Jan-12,NA,NA,St PierreLUMB 21 ,PNC Seq,THIRD,LUMB,19-Jun-60,12-May-11,06-Jun-11,tumorectomy,dissection,ductal,0,0,NA,0,NA,16,NA,NA,NA,0,8,9,3,8,8,1,8,8,1,0,NA,NA,0,30,1,1,1,1,0,3 FEC_3 T_letrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,25-Jan-12,NA,NA,LUMB 22 ,PNC Seq,THIRD,LUMB,29-May-56,26-May-09,26-May-09,tumorectomy,dissection,ductal,0,0,NA,0,NA,13,NA,NA,NA,0,2,8,3,8,8,1,7,8,1,0,NA,NA,0,40,0,1,1,1,0,6 taxotere-xeloda_tamoxifen_letrozole,NA,NA,NA,NA,NA,NA,NA,NA,NA,21-Feb-12,NA,NA,MINDACT (both high clinical and genomic risk)LUMB 23 ,PNC Seq,THIRD,LUMB,21-Feb-56,30-May-11,30-May-11,tumorectomy,sentinelle,ductal,0,0,NA,0,NA,13,NA,NA,NA,0,3,9,3,8,8,1,7,8,1,0,NA,NA,0,20,1,1,1,1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16-Jan-12,NA,NA,St Pierre